首页> 外文期刊>Regenerative medicine >Heart valve tissue engineering: an overview of heart valve decellularization processes
【24h】

Heart valve tissue engineering: an overview of heart valve decellularization processes

机译:心脏瓣膜组织工程:心脏瓣膜脱细胞化过程的概述

获取原文
获取原文并翻译 | 示例
           

摘要

Despite recent advances in medicine and surgery, many people still suffer from cardiovascular diseases, which affect their life span and morbidity. Regenerative medicine and tissue engineering are novel approaches based on restoring or replacing injured tissues and organs with scaffolds, cells and growth factors. Scaffolds are acquired from two major sources, synthetic materials and naturally derived scaffolds. Biological scaffolds derived from native tissues and cell-derived matrix offer many advantages. They are more biocompatible with a higher affinity to cells, which facilitate tissue reconstruction. Interestingly, xenogeneic recipients generally tolerate their components. Therefore, heart valve tissue engineering is increasingly benefiting from naturally derived scaffolds. In this review, we investigated the different protocols and methods that have been used for heart valve decellularization.
机译:尽管最近医学和手术进展,但许多人仍然患有心血管疾病,这影响了他们的生命跨度和发病率。 再生医学和组织工程是基于恢复或用支架,细胞和生长因子的恢复或替换受伤组织和器官的新方法。 支架是从两个主要来源,合成材料和天然衍生的支架中获得的。 来自天然组织和细胞衍生的基质的生物支架提供了许多优点。 它们更加生物相容性,对细胞具有更高的亲和力,这促进了组织重建。 有趣的是,异种受者通常容忍其组分。 因此,心脏瓣膜组织工程越来越受益于天然衍生的支架。 在本综述中,我们调查了已用于心脏瓣膜脱细胞化的不同协议和方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号